Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: codeine / meperidine / iodine containing agents classifier attending: chief complaint: autoimmune hepatitis hcc major surgical or invasive procedure: left hepatic lobectomy, caudate lobe resection, cholecystectomy, intraoperative ultrasound. history of present illness: the patient is a 68-year-old male with a history of auto-immune hepatitis and cirrhosis who developed right upper quadrant abdominal pain. an ultrasound demonstrated a large mass in the right lobe of the liver that on biopsy was consistent with hepatocellular carcinoma. his afp was 336. a ct scan of the chest and abdomen demonstrated no evidence of pulmonary metastases. the patient had a large mass lesion measuring 12.7 x 9.2 x 11.2 cm arising primarily in the medial segment of the left lobe. the middle hepatic vein was not visualized but the right hepatic vein and the left lateral segment hepatic veins were identified. the mass lesion superiorly appears to abut not invade the right lobe of the liver. the patient does not have evidence of portal hypertension. the patient after informed consent is now brought to the operating room for left hepatic lobectomy, possible left trisegmentectomy, caudate lobe resection and cholecystectomy. past medical history: hyperchol, htn, cad s/p cabg (echo --> ef 50%), niddm social history: he has no history of alcohol use, smoking, iv drug use, tattoos, or marijuana use. bs degree. retired in . he was an accountant for over 48 years with . he has seven children and 20 grandchildren. family history: diabetes, hypertension, prostate cancer, colon cancer. his mother is alive at age 88. his father died at age 88 of prostate cancer. physical exam: discharge pe: vitals: 98.9 82 133/74 20 96% room air nad rrr ctab soft, nd, appropriately tender incision: c/d/i no c/c/e pertinent results: admission labs: 06:27pm blood wbc-8.5# rbc-3.37* hgb-10.7* hct-32.4* mcv-96 mch-31.7 mchc-33.0 rdw-15.2 plt ct-334 06:27pm blood glucose-173* urean-21* creat-1.2 na-136 k-5.2* cl-103 hco3-22 angap-16 06:27pm blood alt-486* ast-788* alkphos-208* totbili-2.4* 06:27pm blood calcium-9.3 phos-5.6* mg-1.5* . discharge labs: 05:07am blood wbc-4.7 rbc-3.16* hgb-10.1* hct-30.7* mcv-97 mch-32.1* mchc-33.0 rdw-14.9 plt ct-282 04:55am blood pt-11.8 ptt-23.2 inr(pt)-1.0 05:07am blood glucose-140* urean-18 creat-1.3* na-136 k-4.7 cl-100 hco3-35* angap-6* 05:07am blood alt-171* ast-56* alkphos-194* amylase-66 totbili-0.8 05:07am blood lipase-123* 05:07am blood albumin-2.6* calcium-8.7 phos-3.4 mg-1.9 brief hospital course: the patient was admitted to dr. hepatobiliary surgery service at the on . he underwent a left hepatic lobectomy, caudate lobe resection, cholecystectomy, intraoperative ultrasound. for details of the operation, please refer to the operative report. his postoperative course was uncomplicated. immediately post-operatively, he was transferred to the sicu. he remained stable in the sicu on pod 1. his pain control was increased and was deemed stable for transfer to the floor. on pod 2, he remained afebrile and had good urine output. his foley catheter was discontinued without difficulty voiding and he was advanced to a clear liquid diet, which he tolerated well. on pod 3, was consulted for his uncontrolled diabetes. his central line was discontinued. he remained afebrile and toelrating a clear liquid diet. he reported no flatus or bowel movements. on pod 4, he continued to remain afebrile. he continued to not have signs of return of bowel fuction and he was given a dulcolax suppository without a bowel movement. his drain continued to have minimal output and it was discontinued. on pod 5, he remained afebrile and tolerating a diabetic diet. he had a fleets enema with a resultant bowel movement and he was started on milk of magnesia. his pain continued to be well-controlled. he was deemed stable for discharge on pod 6, afebrile, tolerating a diabetic diet, ambulating well with good pain control. he will follow-up with dr. and . medications on admission: metoprolol 25mg lisinopril 5mg daily hctz 12.5mg daily pravachol 40mg daily prilosec 20mg daiy iss discharge medications: 1. oxycodone 5 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed for pain. disp:*30 tablet(s)* refills:*0* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed for constipation. disp:*30 capsule(s)* refills:*2* 3. home medications please resume all your previous home medications except for a change in your insulin dosages. you are on glargine 30 units at bedtime. please resume your previous humalog sliding scale. 4. insulin glargine 100 unit/ml solution sig: thirty (30) units (0.3ml) subcutaneous at bedtime. disp:*qs qs* refills:*2* discharge disposition: home discharge diagnosis: autoimmune hepatitis hcc discharge condition: stable discharge instructions: please call your physician or go to the emergency room for the following: - chest pain - shortness-of-breath - increased redness or drainage from your wounds - temperature > 101.5 - inability to tolerate food - or other concerns . please take your pain medication and stool softener as prescribed. . no heavy activity or lifting (anything that makes you strain) for 4-6 weeks. continue to ambulate. you may shower, but no baths for 4-6 weeks. . please keep a journal of your blood sugars to bring to your follow-up appointment with dr. . followup instructions: please call dr. at ( to schedule a follow-up appointment. . please follow-up with your primary care physician 1 week from your date of discharge. . please call dr. () at for a follow-up appointment. md, procedure: cholecystectomy other lysis of peritoneal adhesions biopsy of lymphatic structure division or crushing of other cranial and peripheral nerves regional lymph node excision lobectomy of liver diagnoses: obstructive sleep apnea (adult)(pediatric) pure hypercholesterolemia unspecified essential hypertension cirrhosis of liver without mention of alcohol coronary atherosclerosis of unspecified type of vessel, native or graft aortocoronary bypass status peritoneal adhesions (postoperative) (postinfection) long-term (current) use of insulin other chronic hepatitis malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled obesity, unspecified personal history of urinary calculi 

Answer: The patient is high likely exposed to